Canada markets close in 1 hour 3 minutes

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
73.11-0.78 (-1.06%)
As of 02:57PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close73.89
Open74.09
Bid73.17 x 1000
Ask73.18 x 800
Day's Range72.67 - 74.31
52 Week Range68.44 - 91.40
Volume9,260,312
Avg. Volume16,702,396
Market Cap186.016B
Beta (5Y Monthly)0.47
PE Ratio (TTM)25.80
EPS (TTM)2.83
Earnings DateFeb. 03, 2022
Forward Dividend & Yield2.76 (3.74%)
Ex-Dividend DateDec. 14, 2021
1y Target Est94.79
  • Editor's Pick
    Yahoo Finance Video

    COVID: ‘We need to stop wearing cloth masks and go to N95s for all,’ expert says

    Jose Luis Jimenez, University of Colorado at Boulder professor of chemistry and CIRES fellow, joins Yahoo Finance Live to give his expert opinion on where investments in masks and ventilation could aid in lowering COVID transmission rates.

  • Reuters

    UPDATE 1-Merck to supply up to 1 mln courses of COVID-19 pill to Canada

    Merck & Co said on Friday it would supply Canada with up to 1 million courses of molnupiravir, its experimental oral antiviral medicine for the treatment of COVID-19. The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said. Merck said it had filed the final molnupiravir real-time application seeking approval in Canada last month.

  • Reuters

    Merck to supply up to 1 mln courses of COVID-19 pill to Canada

    Merck & Co said on Friday it would supply the Canada with up to 1 million courses of molnupiravir, its experimental oral antiviral medicine for the treatment of COVID-19. The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said.